LETTER
Chem. Ber. 1963, 802.
(6) Contini, A.; Erba, E.; Trimarco, P. ARKIVOC 2008, (xii),
136.
Synthesis of Pentyl-Sulfonyl Amidines
1525
(1.9 g, 62%); [α] –78.2 (c 1, CHCl3). 1H NMR (200 MHz,
CDCl3): δ = 1.70–2.26 (m, 8 H, 4 CH2), 2.37 and 2.44 (2 s,
6 H, 2 CH3Ph), 2.91–2.99 (m, 2 H, CH2), 3.45 (s, 3 H,
CH3O), 3.46–3.74 (m, 2 H, CH2), 4.02–4.08 (m, 2 H, CH2O),
4.43–4.49 (m, 1 H, CH), 7.21 (d, J = 8.16 Hz, 2 H, ArH),
7.35 (d, J = 8.10 Hz, 2 H, ArH), 7.71 (d, J = 8.16 Hz, 2 H,
ArH), 7.78 (d, J = 8.10 Hz, 2 H, ArH). 13C NMR (50 MHz,
CDCl3): δ = 21.6 (CH3), 21.8 (CH3), 22.5 (CH2), 24.8 (CH2),
28.9 (CH2), 29.3 (CH2), 31.7 (CH2), 48.2 (CH2), 52.2 (CH3),
61.1 (CH), 70.0 (CH2), 126.3 (CH), 128.1 (CH), 129.3 (CH),
130.2 (CH), 133.1 (C), 141.3 (C), 142.1 (C), 145.1 (C),
166.4 (C), 171.9 (C). ESI-HRMS: m/z calcd for
(7) Bae, I.; Han, H.; Chang, S. J. Am. Chem. Soc. 2005, 2038.
(8) Liu, M. T. H. Chem. Soc. Rev. 1982, 127.
(9) General Procedure for the Preparation of Amidine 2a–e
The proline methyl ester hydrochloride (1 g, 0.006 mol) was
suspended in toluene (20 mL), and an equivalent amount of
NaOMe (6 mL of 1 M solution) was added. After 30 min the
solvent was concentrated to 10 mL under vacuum, and 5 g of
molecular sieves were added. To the stirred mixture were
added at first cyclopentanone (0.5 g, 0.006 mol) and after 15
min tosylazide (0.92 g, 0.006 mol). The reaction was
monitored with TLC (EtOAc–hexane = 1:1), and after 15
min the tosylazide was completely disappeared. The suitable
reactant was added (0.012 mol), and the stirring was
continued for 1 h. Then the mixture was filtered, and toluene
was removed under vacuum. The crude was dissolved in
CH2Cl2, washed with H2O (10 mL), dried with Na2SO4,
filtered, and the filtrate concentrated in vacuo. The crude
was purified by silica gel chromatography (EtOAc–hexane =
1:1) affording the pure amidines 1a,b and 2a–e
C25H37N2O7S2: 536.1650; found: 536.1651.
Methyl 1-{5-[(2-{[(tert-Butoxy)carbonyl]amino}-
propanoyl)oxy]-1-(tosylimino)pentyl}pyrrolidine-2-
carboxylate (2d)
Colorless oil (2.1, 65%); [α]D –2.29 (c 1, CHCl3). 1H NMR
(200 MHz, CDCl3): δ = 1.39–144 (m, 12 H, 4 CH3), 1.85–
2.29 (m, 8 H, 4 CH2), 2.37 (s, 3 H, CH3Ph), 2.82–3.21 (m, 2
H, CH2), 3.45 (s, 3 H, CH3O), 3.46–3.75 (m, 2 H, CH2),
4.05–4.25 (m, 3 H, CH and CH2), 4.43–4.49 (m, 1 H, CH),
5.08–5.15 (m, 1 H, NH), 7.22 (d, J = 8.18 Hz, 2 H, ArH),
8.73 (d, J = 8.18 Hz, 2 H, ArH). 13C NMR (50 MHz, CDCl3):
δ = 18.8 (CH3), 21.6 (CH3), 23.0 (CH2), 24.8 (CH2), 28.5
(CH3), 29.3 (CH2), 32.0 (CH2), 48.1 (CH2), 49.5 (CH3), 52.2
(CH3), 61.1 (CH), 64.6 (CH2), 79.9 (C), 126.4 (CH), 129.1
(CH), 141.3 (C), 142.1 (C), 155.4 (C), 166.6 (C), 172.0 (C),
173.6 (C). ESI-HRMS: m/z calcd for C26H39N3O8S:
553.2457; found: 553.2458.
Methyl 1-[5-Chloro-1(tosylimino)pentyl]pyrrolidine-2-
carboxylate (1)
Colorless oil (1.68 g, 70%); [α]D –79.8 (c 1, CHCl3). 1H
NMR (300 MHz, CDCl3): δ = 1.92–2.08 (m, 6 H, 3 CH2),
2.09–2.19 and 2.20–2.28 (2 m, 2 H, CH2), 2.40 (s, 3 H,
CH3Ph), 2.85–2.92 and 2.99–3.08 (2 m, 2 H, CH2), 3.49 (s,
3 H, OCH3), 3.58–3.64 (m, 2 H, CH2Cl), 3.61–3.68 and
3.73–3.80 (2 m, 2 H, CH2N), 4.49–4.54 (m, 1 H, CH),
7.25(d, J = 8.20 Hz, 2 H, ArH), 7.77 (d, J = 8.20 Hz, 2 H,
ArH). 13C NMR (75 MHz, CDCl3): δ = 21.6 (CH3), 23.6
(CH2), 24.8 (CH2), 29.3 (CH2), 31.6 (CH2), 32.3 (CH2), 44.5
(CH2), 48.1 (CH2), 52.2 (CH3), 61.1 (CH), 126.3 (CH), 129.3
(CH), 141.3 (C), 142.1 (C), 166.6 (C), 172.0 (C). ESI-
HRMS: m/z calcd for C18H25ClN2O4S: 400.1223; found:
400.1220.
Methyl 1-[5(4-Nitrophenyloxy)-1-(tosylimino)pentyl]-
pyrrolidine-2-carboxylate (2e)
Colorless oil (1.0g, 35%); [α]D –99.5 (c 1, CHCl3). 1H NMR
(200 MHz, CDCl3): δ = 1.82–2.23 (m, 8 H, 4 CH2), 2.37 (s,
3 H, CH3Ph), 2.87–3.12 (m, 2 H, CH2), 3.45 (s, 3 H, CH3),
3.54–3.73 (m, 2 H, CH2), 4.05–4.21 (m, 2 H, CH2), 4.45–
4.51 (m, 1 H, CH), 6.94 (d, J = 8.16 Hz, 2 H, ArH), 7.20 (d,
J = 8.06 Hz, 2 H, ArH), 7.73 (d, J = 8.06 Hz, 2 H, ArH), 8.19
(d, J = 8.16 Hz, 2 H, ArH). 13C NMR (50 MHz, CDCl3): δ =
21.6 (CH3), 23.2 (CH2), 24.8 (CH2), 29.0 (CH2), 29.3 (CH2),
32.1 (CH2), 48.1 (CH2), 52.2 (CH3), 61.1 (CH), 68.3 (CH2),
114.7 (CH2), 126.1 (CH), 126.35 (CH), 129.2 (CH), 129.3
(CH), 141.3 (C), 141.7 (C), 142.1 (C), 164.2 (C), 166.5 (C),
172.0 (C). ESI-HRMS: m/z calcd for C24H29N3O7S:
503.1726; found: 503.1724.
Methyl 1-[5-(Benzoyloxy)-1-(tosylimino)pentyl]-
pyrrolidine-2-carboxylate (2a)
Colorless oil (1.8g, 65%); [α]D –67.8 (c 1, CHCl3). 1H NMR
(200 MHz, CDCl3): δ = 1.82–2.25 (m, 6 H, 3 CH2), 2.37 (s,
3 H, CH3Ph), 2.87–3.13 (m, 2 H, CH2), 3.45 (s, 3 H, OCH3),
3.50–3.75 (m, 3 H, CH2), 4.34–4.401 (m, 2 H, OCH2), 4.42–
4.51 (m, 1 H, CH), 7.20 (d, J = 8.20 Hz, 2 H, ArH), 7.30–
7.60 (m, 3 H, ArH), 7.73–7.85 (m, 2 H, ArH), 8.00 (d,
J =8.20 Hz, 2 H, ArH). 13C NMR (50 MHz, CDCl3): δ = 21.6
(CH3), 23.2 (CH2), 24.8 (CH2), 28.9 (CH2), 29.3 (CH2), 32.1
(CH2), 48.1 (CH2), 52.2 (CH3), 61.1 (CH), 64.4 (CH2), 126.4
(CH), 128.6 (CH), 129.1 (CH), 129.8 (CH), 130.5 (C), 133.1
(CH), 141.4 (C), 142.0 (C), 166.7 (C), 172.0 (C). ESI-
HRMS: m/z calcd for C25H30N2O6S: 486.1824; found:
486.1822.
5-Morpholino-5-(tosylimino)pentyl Benzoate (2f)
Morpholine (0.2 g, 0.0023 mol) and cyclopentanone (0.19 g,
0.0023 mol) were dissolved in CH2Cl2 (10 mL), and 2 g of
molecular sieves were added. The mixture was stirred for 30
min, and tosylazide (0.35 g, 0.0023 mol) was added. After 15
min benzoic acid (0.56 g, 0.0046 mol) was added, and the
stirring was continued for 1 h. Then the mixture was filtered,
washed with H2O (10 mL), dried with Na2SO4, filtered, and
the filtrate was concentrated in vacuo. The crude was
purified by silica gel chromatography (EtOAc–hexane =
1:1) affording the pure 2f. Colorless oil (0.68g, 68%). 1H
NMR (200 MHz, CDCl3): δ = 1.64–2.01 (4 H, m, 2 CH2),
2.38 (3 H, s, CH3Ph), 2.97–3.10 (2 H, m, CH2), 3.42–3.78 (8
H, m, 4 CH2-morpholine), 4.25–4.39 (2 H, m, CH2O), 7.23
(2 H, d, J = 8.20 Hz, ArH), 7.42–7.61 (3 H, m, ArH), 7.90 (2
1-[5-Acetyloxy-1-(tosylimino)pentyl]pyrrolidine-2-
carboxylate (2b)
Colorless oil (1.8g, 72%); [α]D –80.9 (c 1, CHCl3). 1H NMR
(200 MHz, CDCl3): δ = 1.78–2.24 (m, 8 H, 4 CH2), 2.05 (s,
3 H, CH3CO), 2.38 (s, 3 H, CH3), 2.89–3.18 (m, 2 H, CH2),
3.46 (s, 3 H, CH3O), 3.53–3.76 (m, 2 H, CH2), 4.07–5.18 (m,
2 H, CH3O), 4.46–4.52 (m, 1 H, CH), 7.22 (d, J =8.20 Hz, 2
H, ArH), 7.74 (d, J = 8.20 Hz, 2 H, ArH). 13C NMR (50MHz,
CDCl3): δ = 21.2 (CH3), 21.6 (CH3), 23.2 (CH2), 24.8 (CH2),
28.8 (CH2), 29.3 (CH2), 32.1 (CH2), 48.1 (CH2), 52.3 (CH3),
61.1 (CH), 63.9 (CH2), 126.4 (CH), 129.1 (CH), 141.3 (C),
142.1 (C), 166.7 (C), 172.0 (C). ESI-HRMS: m/z calcd for
C20H28N2O6S: 424.1668; found: 424.1666.
H, d, J = 8.15 Hz, ArH), 8.02 (2 H, d, J = 8.20 Hz, ArH). 13
C
NMR (50 MHz, CDCl3): δ = 21.6 (CH3), 23.8 (CH2), 28.9
(CH2), 30.3 (CH2), 45.0 (CH2), 46.8 (CH2), 64.1 (CH2), 66.5
(CH2), 66.7 (CH2), 126.4 (CH), 128.7 (CH), 129.4 (CH),
129.7 (CH), 130.4 (C), 133.3 (CH), 141.4 (C), 142.3 (C),
166.7 (C), 167.4 (C). ESI-HRMS: m/z calcd for
C23H28N2O5S: 444.1718; found: 444.1719.
Methyl 1-[1-(Tosylimino)-5-(tosyloxy)pentyl]-
pyrrolidine-2-carboxylate (2c)
This reaction was performed in cyclohexane. Colorless oil
(10) Pilari, T.; Tron, G. C.; Masson, G.; Zhu, J. Org. Lett. 2007,
5275.
© Georg Thieme Verlag Stuttgart · New York
Synlett 2012, 23, 1523–1525